BRD2 Antikörper (AA 675-725)
-
- Target Alle BRD2 Antikörper anzeigen
- BRD2 (Bromodomain Containing 2 (BRD2))
-
Bindungsspezifität
- AA 675-725
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser BRD2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunoprecipitation (IP)
- Verwendungszweck
- Mouse anti-BRD2 Monoclonal Antibody, Affinity Purified [12C2E4]
- Homologie
- Mouse,Bovine,Dog,Horse,Guinea pig_10141,Pig,Panda,Orangutan,Monkey,Gorilla,Chimpanzee,Crab-eating macaque,White-tufted-ear marmoset,African elephant,Gray short-tailed opossum,Naked mole rat,Chinese hamster,Thirteen-lined ground squirrel,Tasmanian devil,Northern white-cheeked gibbon
- Aufreinigung
- Affinity Purified
- Immunogen
- between AA 675 and 725
- Klon
- 12C2E4
- Isotyp
- IgG
- Top Product
- Discover our top product BRD2 Primärantikörper
-
anti-Bromodomain Containing 2 (BRD2) (AA 227-364) antibody
BRD2 Reaktivität: Human, Ratte WB, ELISA, IHC, ICC, FACS Wirt: Maus Monoclonal 7C1B10 unconjugated
anti-Bromodomain Containing 2 (BRD2) (AA 167-256) antibodyBRD2 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 3D10 unconjugated
anti-Bromodomain Containing 2 (BRD2) (AA 1-100) antibodyBRD2 Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Bromodomain Containing 2 (BRD2) (AA 170-200) antibodyBRD2 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB3416 unconjugated
anti-Bromodomain Containing 2 (BRD2) (AA 524-573) antibodyBRD2 Reaktivität: Human, Maus, Rind (Kuh), Hund, Ratte, Pferd, Schwein, Hamster, Affe WB, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Bromodomain Containing 2 (BRD2) (AA 227-364) antibodyBRD2 Reaktivität: Human WB, ELISA, IHC, ICC, FACS Wirt: Maus Monoclonal 1H6B12 unconjugated
anti-Bromodomain Containing 2 (BRD2) (AA 1-801) antibodyBRD2 Reaktivität: Human WB, IF Wirt: Maus Polyclonal unconjugated
anti-Bromodomain Containing 2 (BRD2) antibodyBRD2 Reaktivität: Maus WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Bromodomain Containing 2 (BRD2) (AA 1-801) antibodyBRD2 Reaktivität: Human IP Wirt: Kaninchen Polyclonal unconjugated
anti-Bromodomain Containing 2 (BRD2) (C-Term) antibodyBRD2 Reaktivität: Human, Hamster WB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
IP: 20 μL/mg lysate
WB: 17:40:00
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 40 μg/mL
- Buffer
- Tris-buffered Saline containing 0.1 % BSA and 0.09 % Sodium Azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
- Haltbarkeit
- 12 months
-
- Target
- BRD2 (Bromodomain Containing 2 (BRD2))
- Andere Bezeichnung
- BRD2 (BRD2 Produkte)
- Synonyme
- D6S113E antikoerper, FSH antikoerper, FSRG1 antikoerper, NAT antikoerper, RING3 antikoerper, RNF3 antikoerper, AW228947 antikoerper, D17H6S113E antikoerper, Frg-1 antikoerper, Fsrg-1 antikoerper, Fsrg1 antikoerper, Nat antikoerper, Ring3 antikoerper, Rnf3 antikoerper, mKIAA4005 antikoerper, brd2-a antikoerper, fsh antikoerper, fsrg1 antikoerper, nat antikoerper, ring3 antikoerper, rnf3 antikoerper, brd2 antikoerper, fe47f02 antikoerper, fi85h05 antikoerper, wu:fe47f02 antikoerper, wu:fi85h05 antikoerper, Ring3 protein antikoerper, bromodomain containing 2 antikoerper, bromodomain containing 2 S homeolog antikoerper, bromodomain containing 2a antikoerper, CHLREDRAFT_190116 antikoerper, CHLREDRAFT_150233 antikoerper, CHLREDRAFT_182576 antikoerper, CHLREDRAFT_188250 antikoerper, BRD2 antikoerper, Brd2 antikoerper, brd2.S antikoerper, brd2a antikoerper
- Hintergrund
- Background: BRD2 (bromodomain-containing 2) is a nuclear mitogen-activated kinase that plays a role in transcription of cell-cycle-regulated genes by functioning as an adapter protein that recruits E2F and chromatin remodeling factors to E2F response elements.
- Gen-ID
- 6046
- NCBI Accession
- NP_005095
- UniProt
- P25440
- Pathways
- Chromatin Binding, SARS-CoV-2 Protein Interaktom, Phosphorylierungen bei SARS-CoV-2 Infektion
-
